ArticleCirculation research2019
A Proteomic Perspective on Cardiomyocyte Maturation.
Naoto Muraoka, Bingyun Sun, Charles E Murry
Abstract readEditorialComment
In one paragraphArticle in Circulation research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
3 authors.
Naoto MuraokaFrom the Institute for Stem Cell and Regenerative Medicine (N.M., C.E.M.), Department of Pathology, University of Washington, Seattle.
Bingyun SunDepartments of Chemistry (B.S.), Simon Fraser University, Burnaby, British Columbia.
Charles E MurryFrom the Institute for Stem Cell and Regenerative Medicine (N.M., C.E.M.), Department of Pathology, University of Washington, Seattle.
Funding
University of Washington Center for Nuclear Organization and FunctionU54DK107979 · NIDDK · UNIVERSITY OF WASHINGTON · PI NOBLE, WILLIAM STAFFORD, SHENDURE, JAY ASHOK · 2015 to 2019
$11.8MEngineered Stem Cells for Cardiac RepairR01HL128368 · NHLBI · UNIVERSITY OF WASHINGTON · PI REGNIER, MICHAEL · 2018 to 2025
$6.1MPrimate Heart RegenerationR01HL128362 · NHLBI · UNIVERSITY OF WASHINGTON · PI MURRY, CHARLES E · 2016 to 2019
$3.5MMechanisms of Cell-Based Heart RegenerationR01HL146868 · NHLBI · UNIVERSITY OF WASHINGTON · PI MURRY, CHARLES E, SNIADECKI, NATHAN JOHN · 2019 to 2022
$3.5MPerfusable 3D human cardiac constructs for heart regenerationR01HL141570 · NHLBI · UNIVERSITY OF WASHINGTON · PI MURRY, CHARLES E, ZHENG, YING · 2018 to 2021
$3.3MNHLBI NIH HHS R01 HL128362NHLBI NIH HHS R01 HL128368NHLBI NIH HHS R01 HL141570NHLBI NIH HHS R01 HL146868NIDDK NIH HHS U54 DK107979
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Induced Pluripotent Stem CellsPluripotent Stem CellsHumansMyocytes, CardiacProteomicsbiologycellsdrug discoveryEditorialpluripotent stem cellsproteomics
Identifiers
PMID31697629
PMCPMC7003684
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390